Afinitor

Developed to target cancer cells to support tumour growth suppression.

Dosage

Pack size

You will receive a quality generic equivalent of Afinitor, depending on stock.

Prescription and consultation requirements for Afinitor vary by destination and are determined by the fulfilment partner.

Afinitor details

Conditions: Renal Cell Carcinoma · Breast Cancer · Neuroendocrine Tumours
Therapeutic class: MTOR Inhibitor
Pharmacological class: Antineoplastic Agent
Contraindications: hypersensitivity to everolimus; hypersensitivity to sirolimus
Precautions and warnings: monitor blood glucose; risk of infection; regular blood count monitoring
Minor side effects: stomatitis; fatigue; rash
Moderate side effects: infections; pneumonitis; anaemia
Dosage forms: Tablet
Administration route: Oral use
Patient summary: developed to target cancer cells to support tumour growth suppression.
Supply category: Prescription-only medicine (POM)
Originator: Novartis
Onset Time: varies per patient
Duration: 24 hours
Storage instructions: Store below 25°C. Protect from light.
Drug interactions: cytochrome p450 inhibitors; grapefruit
Pregnancy and breastfeeding: Pregnancy: must not be used. Breastfeeding: must not be used.

Serious side effects

interstitial lung disease, requires immediate medical attention; severe infections, requires immediate medical attention

Mechanism of action

Everolimus is a serine-threonine kinase inhibitor that acts as an mTOR inhibitor, reducing tumour cell proliferation and angiogenesis.

Afinitor is the originator brand name, made by Novartis. We use it to identify the medicine and are not affiliated with Novartis.

The fulfilment partner confirms whether the exact brand or an equivalent containing Everolimus is offered.
The offered brand, manufacturer and dispatch location depend on the product, destination and partner warehouse.
Check the final product details at checkout before confirming an order.